The Healing Properties of Hemp for Pets

The Healing Properties of Hemp for Pets: A Scientific Overview

Hemp, a variety of the Cannabis sativa plant with low levels of delta-9-tetrahydrocannabinol (THC <0.3%), has gained attention in veterinary medicine primarily for its non-psychoactive cannabinoid cannabidiol (CBD). Derived from hemp, CBD interacts with the endocannabinoid system (ECS), a network of receptors (CB1 and CB2) involved in regulating pain, inflammation, mood, immune response, and more in mammals—including dogs and cats.

While anecdotal reports from pet owners abound, scientific evidence remains emerging. Most research focuses on dogs, with limited studies on cats. No hemp-derived CBD products are currently licensed or FDA-approved for veterinary use, and products vary widely in quality, labeling accuracy, and purity. Always consult a veterinarian before use, as CBD can interact with medications and may cause mild side effects like elevated liver enzymes (e.g., alkaline phosphatase).

Key Potential Benefits Supported by Research

1. Pain Management and Osteoarthritis

Osteoarthritis (OA) is common in aging pets, causing chronic pain and reduced mobility. Several studies suggest hemp-derived CBD may help alleviate discomfort.

• In a Cornell University study, dogs with OA receiving CBD showed pain reduction in over 80% of cases, improving comfort and activity.

• A 2024 crossover trial with full-spectrum hemp oil (2 mg/kg twice daily for 8 weeks) in 37 dogs with household pain reported a 46.2% decrease in pain scores, better stair navigation (10.6–14.7% improvement), and 25.9% increased daily activity. Pro-inflammatory cytokines (TNF-α, IL-6, IL-8) also decreased.

• Pilot studies and reviews (including 2018–2025) indicate CBD reduces pain and boosts activity in OA dogs, often as an adjunct to conventional treatments like NSAIDs.

For cats, a 2025 field study using CBD/CBDA-rich hemp paste showed significant pain score reductions in osteoarthritic cats after 2–6 weeks.

Evidence is promising but often from small samples or short-term trials. Benefits appear linked to CBD's anti-inflammatory and analgesic effects via ECS modulation.

2. Seizure Control (Epilepsy)

Idiopathic epilepsy affects many dogs. CBD has shown anticonvulsant potential.

• Colorado State University trials reported reduced seizure frequency (25–30% in some cases) with CBD-rich hemp.

• Systematic reviews note improvements in seizure management, with no serious adverse events in relevant studies.

Research in cats is sparse, but preliminary data suggests similar mechanisms.

3. Skin Conditions (e.g., Atopic Dermatitis/Pruritus)

Itchy skin from allergies is prevalent. CBD may reduce pruritus through anti-inflammatory pathways.

• A study on canine atopic dermatitis found CBD-containing hemp oil decreased itching when used as a supplement.

• Reviews highlight potential for pruritus relief in dogs.

4. Anxiety and Behavioral Support

Stress-related behaviors (e.g., during events) may improve.

• A Cornell study showed 83% of dogs given CBD chews before stressors exhibited fewer anxiety behaviors.

• Long-term use in large datasets (e.g., Dog Aging Project) suggested reduced aggression over time in supplemented dogs.

• However, 2025 AVMA reports note insufficient evidence for behavioral disorders, with no strong support yet.

5. Other Areas

Limited evidence exists for post-surgical pain, inflammation, or adjunctive cancer care (e.g., no interference with chemotherapy in one lymphoma study). Hemp seed oil provides omega fatty acids for skin/coat health, but this is distinct from cannabinoid effects.

Safety and Tolerability

Hemp-derived CBD (low/no THC) appears well-tolerated in short- and medium-term studies:

• Doses of 2–10 mg/kg/day (often 4–5 mg/kg) cause mild effects like increased ALP (liver enzyme), occasional GI upset, or lethargy.

• Long-term trials (up to 36 weeks at 5 mg/kg) show good tolerance, though higher doses (10 mg/kg) may increase side effects.

• Cats absorb CBD differently (lower concentrations), with some studies noting head-shaking or licking during administration.

• THC-containing products risk toxicity (ataxia, hypothermia); stick to hemp-derived, THC-compliant items.

Product quality varies—some lack claimed cannabinoids or contain contaminants (e.g., heavy metals). Third-party testing is essential.

Current Limitations and Future Directions

• Studies are often small, short-term, or biased toward positive results.

• Optimal dosing, formulations (full-spectrum vs. isolate), and long-term effects need more research.

• No licensed veterinary products exist due to insufficient data for approval.

• Cats have far fewer studies than dogs.

Hemp-derived CBD shows therapeutic promise for pain, seizures, and inflammation in pets, backed by growing veterinary research. However, it's not a cure-all, and evidence isn't conclusive enough for broad recommendations. Pet owners should prioritize veterinary guidance, high-quality products, and monitoring for interactions or side effects.

For the latest, refer to sources like the AVMA, NIH/PubMed veterinary reviews, or consult a vet experienced in cannabinoid therapy. As research evolves, hemp may become a valuable tool in holistic pet care. 🌿🐶🐱